Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine vs Melatonin for Prevention of Postoperative Delirium in Elderly
NCT04189666Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative delirium (POD) comparing Rivastigmine Group with Melatonin Group (2 arms). Primary endpoint: Incidence of developing Postoperative Delirium at Day 7. Started Nov 2019; status: completed.
02
Drugs
rivastigminemelatonin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04189666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189666.